A Systematic Degradation Kinetics Study of Dalbavancin Hydrochloride Injection Solutions.

Area of Science:

• Pharmaceutical Chemistry
• Chemical Kinetics
• Drug Stability

Background:

• Dalbavancin is a lipoglycopeptide antibiotic used for treating serious Gram-positive bacterial infections.
• Understanding the degradation kinetics of dalbavancin is crucial for ensuring its efficacy and safety during storage and administration.

Purpose of the Study:

• To systematically evaluate the degradation kinetics of dalbavancin in solution across a wide pH range (1-12) at an elevated temperature (70°C).
• To identify the primary degradation products and elucidate the degradation pathways under different pH conditions.
• To predict the shelf-life of dalbavancin solutions based on stability data.

Main Methods:

• Degradation kinetics were studied by measuring the decomposition rate of dalbavancin at 70°C as a function of pH, buffer composition, temperature, ionic strength, and drug concentration.
• pH-rate profiles were constructed using pseudo-first-order kinetics, with corrections for buffer effects.
• Degradation products were identified using analytical techniques.

Main Results:

• Dalbavancin degradation is strongly pH-dependent, catalyzed by protons and hydroxyl groups at extreme pH values.
• Maximum stability was observed in the pH region of 4-5.
• Major degradation products identified include Mannosyl Aglycone (MAG) and DB-R6 (acid/thermal), and DB-R2 (base).
• Predicted shelf-life at pH 4.5: 13 years (refrigerated), 8 months (room temperature), 1 month (40°C).

Conclusions:

• Dalbavancin exhibits optimal stability in mildly acidic conditions (pH 4-5).
• Degradation occurs via hydrolytic cleavage and epimerization, yielding specific degradation products.
• The findings provide critical data for formulation development and storage recommendations to maintain dalbavancin integrity.